$125.70 0.2%
Price vs. AI Score (Last 150 days)
Data gathered: March 5

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

Data Bits

Data Bits Value / Change Benchmark
Job Posts 256 13.3%
Sentiment 100 0%
Webpage traffic 235,000 22.1%
Employee Rating 74 0%
Google Trends 58 0%
Patents 430 0%
4chan Mentions 0%
Facebook Engagement 31 10.7%
Facebook followers 34,276 0%
Reddit Mentions 0%
Stocktwits Mentions 1 0%
Stocktwits Subscribers 1,173 0%
Twitter Followers N/A N/A
Twitter Mentions 6 20%
Youtube Subscribers 3,530 0%
News Mentions 2 100%
Customer reviews 0%
Business outlook 63 0%
Linkedin Employees 17,531 N/A

About Zimmer Biomet

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Zimmer Biomet
Price $125.70
Target Price Sign up
Volume 1,660,000
Market Cap $25.7B
Year Range $102.52 - $145
Dividend Yield 0.77%
PE Ratio 25.65
Revenue per Employee $391,894
Industry Medical Devices

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '231.69B1.34B355M163M412M1.650
Q2 '231.8B1.39B414M210M468M1.820
Q1 '231.78B1.35B433M233M461M1.890
Q4 '221.77B2.07B-294M-131M503M1.880
Q3 '221.63B1.27B358M194M377M1.580

Insider Transactions View All

Phipps Chad F filed to sell 44,145 shares at $129.1.
February 26 '24
Phipps Chad F filed to sell 44,755 shares at $128.6.
February 26 '24
Jafry Syed A. filed to buy 4,060 shares at $104.8.
November 13 '23
Kolli Sreelakshmi filed to buy 1,000 shares at $120.4.
September 1 '23
HAGEMANN ROBERT filed to buy 4,000 shares at $116.5.
August 30 '23

Congress Trading View All

Politician Filing Date Type Size
Rohit Khanna
Nov 8, 23 Buy $1K - $15K
Rohit Khanna
Nov 8, 23 Buy $1K - $15K
Rohit Khanna
Nov 8, 23 Buy $1K - $15K

What is the Market Cap of Zimmer Biomet?

The Market Cap of Zimmer Biomet is $25.7B.

What is Zimmer Biomet's PE Ratio?

As of today, Zimmer Biomet's PE (Price to Earnings) ratio is 25.65.

How Many People Work at Zimmer Biomet?

As of our latest update, Zimmer Biomet employed approximately 18,000 people worldwide. However, it's important to note that Zimmer Biomet's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Zimmer Biomet's revenue per employee?

$391,894. To calculate Zimmer Biomet's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current price of Zimmer Biomet?

Currently, the price of one share of Zimmer Biomet is $125.70.

How can I analyze the ZBH stock price chart for investment decisions?

The ZBH stock price chart above provides a comprehensive visual representation of Zimmer Biomet's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Zimmer Biomet shares. Our platform offers an up-to-date ZBH stock price chart, along with technical data analysis and alternative data insights.

Does ZBH offer dividends to its shareholders?

Yes, Zimmer Biomet (ZBH) offers dividends to its shareholders, with a dividend yield of 0.77%. This dividend yield represents Zimmer Biomet's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Zimmer Biomet in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Zimmer Biomet?

Some of the similar stocks of Zimmer Biomet are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.